Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study.
Authors
Haslett, KateAshcroft, Linda
Bayman, Neil A
Franks, K
Groom, N
Hannah, G
Harden, S
Harris, C
Harrow, S
Hatton, M
McCloskey, P
McDonald, F
Ryder, W David J
Faivre-Finn, Corinne
Affiliation
Clinical Oncology, The Christie NHS Foundation Trust, ManchesterIssue Date
2018-01
Metadata
Show full item recordCitation
Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study. 2018, 115(Suppl_1): S62 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(18)30172-7Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500218301727Type
Meetings and ProceedingsISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(18)30172-7